Testicular Tissue Cryopreservation in Children

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT02872532
Status
Recruiting

Conditions

  • Cancer
  • Cancer-Related Condition
  • Infertility

Eligibility Criteria

Sex
MALE
Age
0 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Testicular tissue cryopreservation — PROCEDURE
    Testicular tissue will be removed

Study Details

This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility threatening medical diagnoses or facing surgery, chemotherapy or radiation therapy that may cause loss of reproductive potential.

Key Dates

Start date
Aug 16, 2016
Status verified
Dec 2025
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
200 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Testicular tissue
    Children faced with a fertility threatening diagnosis or treatment plan will be offered testicular tissue cryopreservation, particularly if pre-pubescent and without other options to preserve fertility.

Primary Outcome Measure

Number of pregnancies and live births after transplantation of cryopreserved testicular tissue [ Time Frame: 10-20 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Asma Chattha, MBBS
507-538-0127
Chloe Schluttner
507-293-9555
Candace F. Granberg, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

Related Studies